DPP-4 inhibitors, known as gliptins, are a class of oral diabetic medications approved by the Food and Drug Administration (FDA) to treat type 2 diabetes mellitus in adults. DPP-4 inhibitors that have FDA approval include sitagliptin, saxagliptin, linagliptin, and alogliptin.
People also ask
What drugs are dipeptidyl peptidase 4 inhibitors?
What is the mechanism of action of DPP-4 inhibitors?
What are the benefits of DPP-4 inhibitors?
What is the role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment?
scholar.google.com › citations
Feb 22, 2016 · DPP-4 inhibitors are a class of prescription medicines that are used with diet and exercise to control high blood sugar in adults with type ...
DPP-4 inhibitors, such as sitagliptin and saxagliptin, slow the inactivation and degradation of GLP-1, offering the newest FDA-approved treatment approaches for ...
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and may be used in the treatment of type 2 diabetes.
DPP-4 inhibitors work by blocking the action of DPP-4, an enzyme which destroys the hormone incretin. Incretins help the body produce more insulin only when ...
Aug 28, 2015 · Severe and disabling joint pain has been reported with the use of dipeptidyl peptidase-4 (DPP-4 inhibitors). The time to onset of symptoms ...
Apr 27, 2023 · Dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus. Formulary drug information for this topic.
People also search for
Related treatments
For informational purposes only. Consult your local medical authority for advice.